clot etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
clot etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

6 Ağustos 2014 Çarşamba

Clot Busters For Stroke Gain Far more Help

Though thrombolysis for ischemic stroke has been extensively recognized as useful, its use has been limited due to the fact of issues about its effects on sufferers taken care of after 3 hrs, on older sufferers, and on patients with mild and with extreme strokes. Now a new metaanalysis published in the Lancet offers proof that the use of thrombolysis need to be more aggressively pursued.


Researchesr from the Stroke Thrombolysis Trialists’ Collaborative Group combined patient information from 9 randomized trials testing alteplase (Activase, Roche Pharmaceuticals) with placebo or open control in 6756 sufferers. Thrombolysis was a lot more very likely to lead to a excellent stroke outcome, defined as no considerable disability at 3–6 months, in patients treated inside of four.5 hours:



  • Remedy within three hours: 32.9% for alteplase versus 23.one% for control (OR 1.75, CI one.35–2.27)

  • Treatment method in between 3 and 4.5 hours: 35.3% versus thirty.1%(OR 1.26, CI 1.05–1.51)

  • Treatment method between 3 and four.five hours: 32.six% versus 30.six% (OR 1.15, CI .95–1.40)


The chief disadvantage to thrombolysis was an early and substantial boost in intracranial hemorrhage (fatal ICH at 1 week: 2·7% vs 0·4%). This resulted in a important increase in early mortality, but this distinction was no longer significant at 90 days, even though a trend remained (17.9% versus sixteen.five%, HR 1.eleven, CI .99–1.25, p=0·07)


There were no considerable variations in benefit and chance based on age or stroke severity. Regardless of the early boost in mortality, the authors concluded that thrombolysis was connected with an average absolute improve in disability- cost-free survival of roughly 10% and five% for individuals treated inside three hours and in between three-four.five hrs, respectively.


In an accompanying editorial, Michael Hill and Shelagh Coutts compose that the finding of the metaanalysis is “definitive.” “The question now,” they create, “is not whether or not we can lengthen the window for remedy. Rather, how do we get absolutely everyone taken care of faster and how do we dispel preconceived notions about not treating older patients or those with milder strokes? We should move from the verified science to policy and programs of care.”



Clot Busters For Stroke Gain Far more Help

3 Temmuz 2014 Perşembe

Motörhead fan"s vigorous headbanging leaves him with blood clot on the brain

SHOWBIZ Motorhead_file 1

Motörhead lead singer Lemmy performs with his band. Photograph: Yui Mok/PA




Hefty metal actually can do your head in, in accordance to medical professionals who treated a Motörhead fan with a blood clot on the brain caused by headbanging.


The 50-yr-old German man created the condition following getting carried away at one of the rock band’s concerts.


German doctors say they handled the fan whose headbanging habit in the end led to a brain injury, but that the danger to metal supporters in standard is so little they do not need to give up the shaking.


This is the fourth documented case of subdural haematoma linked to headbanging – a single of which proved fatal.


Professionals handled the fan at Hannover Medical School two weeks after he started suffering a continuous, worsening headache that affected the complete head.


The patient, who was not recognized, had no history of head injuries or substance abuse issues but explained he had been headbanging regularly for years – most recently at a Motörhead concert he attended with his son.


Soon after a scan, physicians identified their patient had a brain bleed and needed a hole drilled into his brain to drain the blood. The patient’s headaches soon disappeared.


In a followup scan, the medical professionals saw he had a benign cyst which may possibly have produced the metal aficionado much more vulnerable to a brain damage.


“We are not towards headbanging,” stated Dr Ariyan Pirayesh Islamian, a single of the medical doctors who treated the guy.


“The danger of injury is very, extremely low. But I think if [the patient] had gone to a classical concert, this would not have took place.”


Islamian said the violent shaking of the head in headbanging can be sufficient to lead to injury as the brain bumps against the skull and mentioned other heavy metal followers had suffered comparable injuries in the previous.


The newest situation was described in a report published on the web on Friday in the Lancet.


A evaluation of the health care literature revealed three earlier instances where headbanging led to blood clots. One particular, an acute haematoma, resulted in sudden death.


Other conditions attributed to headbanging have incorporated a torn carotid artery, a whiplash injury, a fractured neck and air in the chest cavity.


The medical professionals defined headbanging as “a modern dance form consisting of abrupt flexion-extension movements of the head to the rhythm of rock music, most frequently observed in the hefty metal genre”.


Islamian described Motörhead as “a single of the most tough-core rock’n"roll acts on Earth.”


Medical doctors mentioned headbangers need to not be discouraged from enjoying their favourite bands.


“There are most likely other greater chance occasions going on at rock concerts than headbanging,” explained Colin Shieff, a neurosurgeon and trustee of the British brain injury advocacy group Headway.


“Most individuals who go to music festivals and jump up and down although shaking their heads never end up in the hands of a neurosurgeon.”


Islamian agreed that heavy metal followers ought to not automatically skip the headbanging.


“Rock’n"roll will never ever die,” he stated. “Heavy metal fans must rock on.”




Motörhead fan"s vigorous headbanging leaves him with blood clot on the brain

2 Şubat 2014 Pazar

Blood clot warning for 1m contraceptive pill end users

This comes soon after a evaluation by the European Medicines Company which found that the packaging of the tablets must be updated to make certain that girls are produced aware of the dangers of blood clots.


The MHRA wrote a letter to physicians on January 22 which stated that “there is no need to have for anyone who has been utilizing a combined hormonal contraceptive with out any problems to end taking it on the basis of this evaluation”.


It additional: “Combined hormonal contraceptives are hugely effective in avoiding unwanted pregnancy. They supply substantial positive aspects and these far outweigh the modest risk of serious side results.”


Dr Sarah Branch, deputy director of the MHRA’s vigilance and danger management of medicines division, said: “Women ought to carry on to consider their contraceptive pill. These are quite secure, very successful medicines for preventing unintended pregnancy and the positive aspects linked with their use far outweigh the chance of blood clots in veins or arteries.


“No essential new proof has emerged – this overview basically confirms what we already know, that the threat of blood clots with all combined hormonal contraceptives is little.


“If ladies have concerns, they must go over them with their GP or contraceptive provider at their next regimen appointment but should preserve taking their contraceptive until finally they have accomplished so.”


The watchdog has written to the country’s 60,000 GPs telling them they have to, for the 1st time, go by way of a patient checklist when prescribing the pills, in accordance to the Mail on Sunday.


The aim is to prevent the drugs currently being offered to women with a increased inherent danger of building blood clots.


The newer, third generation, of contraceptive pills are prescribed about two million instances a 12 months and have proved common simply because they are significantly less probably to trigger sideeffects this kind of as weight acquire, headaches, breast tenderness and hair development.


DVTs, which usually kind in the leg, can travel up blood vessels to cause a probably fatal blockage in the lung, acknowledged as a pulmonary embolism. They can also travel to the brain, triggering a stroke.


Risk factors consist of being older and overweight, smoking or getting susceptible to a kind of migraine.


Pharmaceutical giant Bayer, which helps make Yasmin and Femodene, explained it would be generating blood clot warnings much more prominent on its packets in the wake of the warning.


The warning letters have gone out to medical doctors across Europe, prompted by a report from France which identified that from 2000 to 2011, 2,529 circumstances of serious blood clots – just over 200 a 12 months – were down to mixed contraceptives.


Of those, one,751, or 146 a 12 months, had been due to third generation pills. These clots led to twenty deaths a 12 months on common, 14 from newer versions of the pill and six from older versions.


That led the authorities in France to tell medical doctors to supply the newer tablets only if their sufferers had initial tried the outdated ones – a tougher response than the MHRA has taken.


Scientists are still investigating the website link in between the newer capsules and severe blood clots, but they suspect that synthetic oestrogen used in the contraceptives might boost the threat.


The third generation drugs had been launched in the 1980s and official issues have been 1st raised about improved DVT risks in 1995.


Dr Asma Khalid, of Marie Stopes Worldwide, mentioned: “Any approach of contraception comes with its own rewards and possible side effects, and it’s crucial that ladies are given the data they require to make informed options.”



Blood clot warning for 1m contraceptive pill end users